Using Secondary Data to Evaluate Sex-based Heterogeneity of GLP-1 Agonists and SGLT2 Inhibitors on Cardiovascular-Kidney-Metabolic Health (CKMH) Outcomes in Real-world Settings (DASH-CKMH)
Clinical trial NCT07188545 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT07188545
- Sponsor
- Ohio State University
- Status
- ACTIVE_NOT_RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2025-09-15
- Primary completion
- 2029-06-30
- Enrollment
- 23280000
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.